Front & Back Matter.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. X, doi. 10.1159/000381612
- Publication type:
- Article
Works matching IS 00093157 AND DT 2015 AND VI 60 AND IP 2
Results: 11
1
2
Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal Cancer.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 73, doi. 10.1159/000368071
- By:
- Publication type:
- Article
3
In vitro Anticancer Activity of Myricanone in Human Lung Adenocarcinoma A549 Cells.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 81, doi. 10.1159/000371738
- By:
- Publication type:
- Article
4
A Case of Hepatic Portal Venous Gas in a Patient Treated with Pemetrexed and Carboplatin for Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 88, doi. 10.1159/000371440
- By:
- Publication type:
- Article
5
Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 91, doi. 10.1159/000370193
- By:
- Publication type:
- Article
6
Effects of Microtubule and Actin Inhibitors on Cryptococcus neoformans Examined by Scanning and Transmission Electron Microscopy.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 99, doi. 10.1159/000371413
- By:
- Publication type:
- Article
7
The Optimal Treatment Modality in Patients with T4N2M0 Non-Small Cell Lung Cancer: The Best Choice May Be Definitive Chemoradiotherapy Followed by Consolidation Chemotherapy.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 107, doi. 10.1159/000371414
- By:
- Publication type:
- Article
8
Combination of Matrine and Sorafenib Decreases the Aggressive Phenotypes of Hepatocellular Carcinoma Cells.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 112, doi. 10.1159/000371736
- By:
- Publication type:
- Article
9
Suppressive Effect of Matrine on Tumor Invasion in N-Butyl-N-(4-Hydroxybutyl)Nitrosamine-Induced Urinary Bladder Carcinogenesis.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 119, doi. 10.1159/000371439
- By:
- Publication type:
- Article
10
A Randomised Phase II Trial Comparing Docetaxel Plus Prednisone with Docetaxel Plus Prednisone Plus Low-Dose Cyclophosphamide in Castration-Resistant Prostate Cancer.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 129, doi. 10.1159/000369781
- By:
- Publication type:
- Article
11
Changes in Gut Microbiota May Be Early Signs of Liver Toxicity Induced by Epoxiconazole in Rats.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 135, doi. 10.1159/000371837
- By:
- Publication type:
- Article